SCHEDULE 13D - CATALINA VALENCIA

Company

AXIM BIOTECHNOLOGIES, INC.

Filed

August 31, 2022

Accession Number

0001096906-22-002069

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →